-
Product Insights
Bronchiectasis Global Clinical Trials Review, H1, 2016
GlobalData's clinical trial report, “Bronchiectasis Global Clinical Trials Review, H1, 2016" provides an overview of Bronchiectasis clinical trials scenario. This report provides top line data relating to the clinical trials on Bronchiectasis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Bronchospasm Global Clinical Trials Review, H1, 2016
GlobalData's clinical trial report, “Bronchospasm Global Clinical Trials Review, H1, 2016" provides an overview of Bronchospasm clinical trials scenario. This report provides top line data relating to the clinical trials on Bronchospasm. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Acute Respiratory Distress Syndrome Global Clinical Trials Review, H1, 2016
GlobalData's clinical trial report, “Acute Respiratory Distress Syndrome Global Clinical Trials Review, H1, 2016" provides an overview of Acute Respiratory Distress Syndrome clinical trials scenario. This report provides top line data relating to the clinical trials on Acute Respiratory Distress Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Sector Analysis
EpiCast Report: Idiopathic Pulmonary Fibrosis – Epidemiology Forecast to 2025
The American Thoracic Society (ATS) defines IPF as a chronic, fibrosing interstitial pneumonia of unknown cause, which occurs primarily in older adults. IPF is characterized by variable degrees of inflammation and scarring and is associated with a histologic or radiologic pattern of usual interstitial pneumonia (UIP). IPF is the most common form of idiopathic interstitial pneumonia, having the worst prognosis, and only three to five years of median survival. IPF is more common in men and the incidence and prevalence...
-
Product Insights
Allergic Rhinitis Global Clinical Trials Review, H1, 2016
GlobalData's clinical trial report, “Allergic Rhinitis Global Clinical Trials Review, H1, 2016" provides an overview of Allergic Rhinitis clinical trials scenario. This report provides top line data relating to the clinical trials on Allergic Rhinitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Bronchitis Global Clinical Trials Review, H1, 2016
GlobalData's clinical trial report, “Bronchitis Global Clinical Trials Review, H1, 2016" provides an overview of Bronchitis clinical trials scenario. This report provides top line data relating to the clinical trials on Bronchitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Chronic Obstructive Pulmonary Disease (COPD) Global Clinical Trials Review, H1, 2016
GlobalData's clinical trial report, “Chronic Obstructive Pulmonary Disease (COPD) Global Clinical Trials Review, H1, 2016" provides an overview of Chronic Obstructive Pulmonary Disease (COPD) clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Obstructive Pulmonary Disease (COPD). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end...
-
Product Insights
Pharyngitis Global Clinical Trials Review, H1, 2016
GlobalData's clinical trial report, “Pharyngitis Global Clinical Trials Review, H1, 2016" provides an overview of Pharyngitis clinical trials scenario. This report provides top line data relating to the clinical trials on Pharyngitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Acute Lung Injury Global Clinical Trials Review, H1, 2016
GlobalData's clinical trial report, “Acute Lung Injury Global Clinical Trials Review, H1, 2016" provides an overview of Acute Lung Injury clinical trials scenario. This report provides top line data relating to the clinical trials on Acute Lung Injury. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Dyspnea Global Clinical Trials Review, H1, 2016
GlobalData's clinical trial report, “Dyspnea Global Clinical Trials Review, H1, 2016" provides an overview of Dyspnea clinical trials scenario. This report provides top line data relating to the clinical trials on Dyspnea. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.